Bornea, Mary An .

HRN: 21-93-03  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/19/2022
AMPICILLIN 1GM (VIAL)
09/19/2022
09/19/2022
IV
2 G
Now Then Q6
PROM X 10 Hrs, MSAF
Waiting Final Action 
09/19/2022
CEFUROXIME 500MG (TAB)
09/19/2022
09/26/2022
ORAL
500mg
BID
PROM
Waiting Final Action 
09/20/2022
CEFUROXIME 1.5GM (VIAL)
09/20/2022
09/21/2022
IV
1.5g
Q8
UTI
09/20/2022
CEFTRIAXONE 1G (VIAL)
09/20/2022
09/27/2022
IV
2gm
OD
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: